Three Directors at Compania De Distribucion Integral Logista bought 16,628 shares at between 28.200EUR and 28.340EUR. The significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the...
>Q4 2024 economic sales +6% y-o-y, above our forecast - Economic sales in Q4 (July-September 2024) were up 4% y-o-y to € 439m. This evolution is exclusively organic as the scope effect from recent acquisitions is now over and above our estimate yet aligned with the consensus. Economic sales were solid in Iberia (+5% y-o-y) helped by a strong tobacco division (+2% y-o-y) which is able to grow not only via prices but also via volume (+0.4% y-o-y), pharma (+19% y-o-y vs...
>Q3 2024 economic sales +6% y-o-y, broadly in line with our forecast - Economic sales in Q3 (April-June 2024) were up 6% y-o-y to € 451m. This evolution is exclusively organic as the scope effect from recent acquisitions is now over and is broadly aligned with our estimate and the consensus. Economic sales were solid in Iberia (+6% y-o-y) helped by a strong tobacco division (+3% y-o-y) helped by RSP increases (€ 0.20/0.25 per pack on average) that provided a € 2m POI...
>New cash pooling agreement with Imperial and rate hedging - The new terms (6M Euribor + 75bp vs ECB +75bp previously) came into force in June 2024 and will be valid for the next three years. The company unveiled during the roadshow that they have hedged the rate at 3.6% for the next three years (vs 6M Euribor at 3.7% today, 3.0% 1Y fwd, 2.7% 2Y fwd and 2.6% 3Y fwd) for the first € 1bn in the cash pooling agreement.The company is still looking for additio...
>Q2 2024 economic sales +1% y-o-y, in line with our forecast - Economic sales in Q2 (January-March 2024) were up 1% y-o-y to € 441m. This evolution is exclusively organic as the scope effect from recent acquisitions is now over and is broadly aligned with our estimate (-1pp) and the consensus (+1pp). Economic sales were solid in Iberia (+3% y-o-y) helped by a strong tobacco (+11% y-o-y), pharma (+8% y-o-y) and others contribution (+8%) that offset the soft transport ...
Nous faisons rentrer aujourd’hui CRH dans notre liste de valeurs recommandées Large Caps. Elle est exposée à l’économie américaine qui va continuer ,selon nous, de se montrer plus dynamique que l’économie européenne, comme en ont attesté les très bons chiffres de création d’emploi vendredi dernier. Elle réalise 75% de son EBITDA dans les 10 Etats américains à plus forte croissance et dispose en outre de catalyseurs techniques positifs comme sa future entrée dans les indices S&P TMI et...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.